JPWO2023008461A5 - - Google Patents

Info

Publication number
JPWO2023008461A5
JPWO2023008461A5 JP2022554213A JP2022554213A JPWO2023008461A5 JP WO2023008461 A5 JPWO2023008461 A5 JP WO2023008461A5 JP 2022554213 A JP2022554213 A JP 2022554213A JP 2022554213 A JP2022554213 A JP 2022554213A JP WO2023008461 A5 JPWO2023008461 A5 JP WO2023008461A5
Authority
JP
Japan
Prior art keywords
seq
variable region
chain variable
amino acid
acid sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022554213A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2023008461A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2022/028877 external-priority patent/WO2023008461A1/ja
Publication of JPWO2023008461A1 publication Critical patent/JPWO2023008461A1/ja
Publication of JPWO2023008461A5 publication Critical patent/JPWO2023008461A5/ja
Pending legal-status Critical Current

Links

JP2022554213A 2021-07-27 2022-07-27 Pending JPWO2023008461A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2021122071 2021-07-27
PCT/JP2022/028877 WO2023008461A1 (ja) 2021-07-27 2022-07-27 癌の治療及び/又は予防のための医薬品

Publications (2)

Publication Number Publication Date
JPWO2023008461A1 JPWO2023008461A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 2023-02-02
JPWO2023008461A5 true JPWO2023008461A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 2025-07-25

Family

ID=85087718

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022554213A Pending JPWO2023008461A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 2021-07-27 2022-07-27

Country Status (8)

Country Link
EP (1) EP4378477A4 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPWO2023008461A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KR (1) KR20240042415A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CN (1) CN117651566A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU2022316644A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA3227703A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
MX (1) MX2024001099A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
WO (1) WO2023008461A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8607679D0 (en) 1986-03-27 1986-04-30 Winter G P Recombinant dna product
ATE340590T1 (de) 1994-07-13 2006-10-15 Chugai Pharmaceutical Co Ltd Gegen menschliches interleukin-8 gerichteter, rekonstituierter menschlicher antikörper
SK14812000A3 (sk) 1998-04-03 2001-08-06 Chugai Seiyaku Kabushiki Kaisha Chimérny reťazec protilátky, chimérna protilátka, v oblasť, humanizovaný reťazec protilátky, humanizovaná protilátka, dna, expresný vektor, hostiteľ, spôsob prípravy a liečivo
WO1999054342A1 (en) 1998-04-20 1999-10-28 Pablo Umana Glycosylation engineering of antibodies for improving antibody-dependent cellular cytotoxicity
US6737056B1 (en) 1999-01-15 2004-05-18 Genentech, Inc. Polypeptide variants with altered effector function
EP3031917A1 (en) 1999-04-09 2016-06-15 Kyowa Hakko Kirin Co., Ltd. Method for controlling the activity of immunologically functional molecule
FR2807767B1 (fr) 2000-04-12 2005-01-14 Lab Francais Du Fractionnement Anticorps monoclonaux anti-d
JP2006524039A (ja) 2003-01-09 2006-10-26 マクロジェニクス,インコーポレーテッド 変異型Fc領域を含む抗体の同定および作製ならびにその利用法
US8388955B2 (en) 2003-03-03 2013-03-05 Xencor, Inc. Fc variants
DE10359795A1 (de) 2003-12-19 2005-07-21 Bayer Technology Services Gmbh Strangverdampfervorrichtung
DK2322221T3 (da) 2008-08-05 2014-09-01 Toray Industries Farmaceutisk sammensætning til behandling og forebyggelse af cancer
JP5918129B2 (ja) 2009-06-22 2016-05-18 メディミューン,エルエルシー 部位特異的共役のための操作されたFc領域
EP2480671B8 (en) 2009-09-22 2015-10-28 ProBioGen AG Process for producing molecules containing specialized glycan structures
AU2011211682B2 (en) 2010-02-04 2015-08-13 Toray Industries, Inc. Pharmaceutical composition for treating and/or preventing cancer
KR101801667B1 (ko) 2010-02-04 2017-11-27 도레이 카부시키가이샤 암의 치료 및/또는 예방용 의약 조성물
PT2532743E (pt) 2010-02-04 2015-08-04 Toray Industries Composição farmacêutica para o tratamento e/ou a prevenção de cancro
KR101842893B1 (ko) 2010-02-04 2018-03-28 도레이 카부시키가이샤 암의 치료 및/또는 예방용 의약 조성물
MX2012008991A (es) 2010-02-04 2012-09-07 Toray Industries Medicamento para tratar y/o prevenir el cancer.
JP5845899B2 (ja) 2010-02-04 2016-01-20 東レ株式会社 癌の治療及び/又は予防用医薬組成物
CA2794708C (en) 2010-03-29 2021-11-16 Zymeworks Inc. Antibodies with enhanced or suppressed effector function
HUE033183T2 (en) 2011-08-04 2017-11-28 Toray Industries A medicament for treating and / or preventing cancer
HUE047006T2 (hu) 2011-08-04 2020-04-28 Toray Industries Anti-caprin-1 antitesteket tartalmazó gyógyászati kompozíció rák kezelésére és/vagy megelõzésére
CA2844040C (en) 2011-08-04 2019-05-07 Toray Industries, Inc. Pharmaceutical composition for treatment and/or prophylaxis of cancer
PT2740489T (pt) 2011-08-04 2017-01-10 Toray Industries Composição farmacêutica para o tratamento e/ou a prevenção do cancro pancreático
MX348579B (es) 2011-08-04 2017-06-20 Toray Industries Composicion farmaceutica para el tratamiento y/o prevencion del cancer.
DK2740795T3 (en) 2011-08-04 2017-01-16 Toray Industries Pharmaceutical composition for the treatment and / or prevention of cancer
WO2013125636A1 (ja) 2012-02-21 2013-08-29 東レ株式会社 癌の治療及び/又は予防用医薬組成物
HUE045461T2 (hu) 2012-02-21 2019-12-30 Toray Industries Gyógyászati készítmény rák kezelésére
AU2013223161B2 (en) 2012-02-21 2017-10-19 Toray Industries, Inc. Medicinal composition for treating and/or preventing cancer
CN104114581B (zh) 2012-02-21 2018-11-30 东丽株式会社 癌的治疗和/或预防用药物组合物
PL2832365T3 (pl) 2012-03-30 2018-04-30 Toray Industries, Inc. Kompozycja farmaceutyczna do leczenia i/lub zapobiegania nowotworowi wątroby
ES2656501T3 (es) 2012-03-30 2018-02-27 Toray Industries, Inc. Composición farmacéutica para el tratamiento y/o la prevención de cáncer de vesícula biliar
CN112587671A (zh) 2012-07-18 2021-04-02 博笛生物科技有限公司 癌症的靶向免疫治疗
MX360671B (es) 2013-08-09 2018-11-13 Toray Industries Composición farmacéutica para el tratamiento y/o prevención del cáncer.
US10593576B2 (en) 2015-03-03 2020-03-17 Brooks Automation (Germany) Gmbh Inspection system
MX2020009862A (es) * 2018-03-30 2020-10-08 Toray Industries Composicion farmaceutica para el tratamiento y/o prevencion de cancer.
EP4119156A4 (en) * 2020-03-12 2024-05-08 Toray Industries, Inc. MEDICINE FOR THE TREATMENT AND/OR PREVENTION OF CANCER

Similar Documents

Publication Publication Date Title
JP2018070648A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP2017048240A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP2019535250A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP2020522486A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
RU2009115363A (ru) Антагонисты рецепторов для лечения метастатического рака
JP2020514310A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP2018508483A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
RU2013136172A (ru) Белки, связывающие антиген фактор роста, подобный гепаринсвязывающему эпидермальному фактору роста
JP2018529312A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP2018504105A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP2014530215A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IL253462B (en) Treatment of cancer with anti-lap monoclonal antibodies
JP2018503365A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
RU2017105915A (ru) Антитела против pd-1
HRP20180262T1 (hr) Monoklonska anti-gt468 protutijela za liječenje karcinoma
JP2010531140A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP2010535713A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FI3941946T3 (fi) Klaudiini-6-vasta-aineita ja klaudiini-6-vasta-ainelääkekonjugaatteja
JP2020517725A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JPWO2019160751A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
RU2018124601A (ru) АНТИТЕЛО К Myl9
JPWO2023008462A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JPWO2023008461A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JPWO2023008459A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JPWO2022270524A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)